Experience with intravenous immunoglobulin in myasthenia gravis: a review.
作者信息
Edan G, Landgraf F
机构信息
Department of Neurology, Centre Hospitalier Régional, Rennes, France.
出版信息
J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):55-6. doi: 10.1136/jnnp.57.suppl.55.
Abstract
摘要
相似文献
1
Experience with intravenous immunoglobulin in myasthenia gravis: a review.静脉注射免疫球蛋白治疗重症肌无力的经验：综述
J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):55-6. doi: 10.1136/jnnp.57.suppl.55.
2
Intravenous immunoglobulin for myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Cochrane Database Syst Rev. 2003(2):CD002277. doi: 10.1002/14651858.CD002277.
3
High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.大剂量静脉注射免疫球蛋白治疗新生儿短暂性重症肌无力
Pediatr Neurol. 1998 Feb;18(2):181-3. doi: 10.1016/s0887-8994(97)00174-4.
4
Intravenous immunoglobulin in neonatal myasthenia gravis.静脉注射免疫球蛋白治疗新生儿重症肌无力
J Pediatr. 1999 Dec;135(6):790. doi: 10.1016/s0022-3476(99)70106-x.
5
[Myasthenia gravis and treatment with intravenous immunoglobulins].[重症肌无力与静脉注射免疫球蛋白治疗]
Rev Neurol. 2016 Nov 1;63(9):431-432.
6
A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.静脉注射免疫球蛋白与血浆置换作为重症肌无力术前治疗方法的疗效比较。
J Clin Neuromuscul Dis. 2008 Mar;9(3):352-5. doi: 10.1097/CND.0b013e3181660807.
7
Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis.血浆置换与静脉注射免疫球蛋白治疗自身免疫性重症肌无力
Ann N Y Acad Sci. 1998 May 13;841:720-6. doi: 10.1111/j.1749-6632.1998.tb11008.x.
8
Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.无菌性脑膜炎作为重症肌无力静脉注射免疫球蛋白治疗的一种并发症。
Muscle Nerve. 1994 Jun;17(6):683-4. doi: 10.1002/mus.880170620.
9
Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis.静脉注射免疫球蛋白治疗新生儿重症肌无力失败。
J Pediatr. 1999 Feb;134(2):233-5. doi: 10.1016/s0022-3476(99)70422-1.
10
Myasthenia gravis: helping patients have better outcomes.重症肌无力：助力患者获得更好的治疗结果。
Nurse Pract. 2012 Sep 10;37(9):30-6; Quiz 36-7. doi: 10.1097/01.NPR.0000418380.60864.21.
引用本文的文献
1
Case Report: A myasthenia gravis patient complicated with renal failure was effectively treated with efgartigimod.病例报告：一名重症肌无力合并肾衰竭的患者接受艾加莫德治疗后效果良好。
Front Immunol. 2025 Mar 27;16:1526975. doi: 10.3389/fimmu.2025.1526975. eCollection 2025.
2
First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report.皮下注射艾加莫德用于治疗即将发生的重症肌无力危象的一线治疗：病例报告
Ther Adv Neurol Disord. 2024 Dec 23;17:17562864241307687. doi: 10.1177/17562864241307687. eCollection 2024.
3
Current Treatment of Myasthenia Gravis.重症肌无力的当前治疗方法
J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.
4
VNTR2/VNTR3 genotype in the gene is associated with reduced effectiveness of intravenous immunoglobulin in patients with myasthenia gravis.该基因中的VNTR2/VNTR3基因型与重症肌无力患者静脉注射免疫球蛋白的疗效降低有关。
Ther Adv Neurol Disord. 2021 Jan 27;14:1756286420986747. doi: 10.1177/1756286420986747. eCollection 2021.
5
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.在自身免疫性神经肌肉疾病中，静脉注射免疫球蛋白（IVIG）能迅速且可逆地产生反应，这表明其作用机制可能涉及与具有重要功能的自身抗体竞争。
J Peripher Nerv Syst. 2013 Dec;18(4):275-96. doi: 10.1111/jns5.12048.
6
Intravenous immunoglobulin in neurological disease: a specialist review.静脉注射免疫球蛋白在神经系统疾病中的应用：专家综述
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):440-8. doi: 10.1136/jnnp.72.4.440.
7
Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.简短报告：静脉注射免疫球蛋白治疗儿童孤独症的开放性临床试验初步研究
J Autism Dev Disord. 1999 Apr;29(2):157-60. doi: 10.1023/a:1023096728131.
本文引用的文献
1
Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.无菌性脑膜炎作为重症肌无力静脉注射免疫球蛋白治疗的并发症。
J Neurol Neurosurg Psychiatry. 1993 Jul;56(7):830-1. doi: 10.1136/jnnp.56.7.830-a.
2
Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G.
Ann N Y Acad Sci. 1993 Jun 21;681:563-6. doi: 10.1111/j.1749-6632.1993.tb22941.x.
3
Strategies for treatment of myasthenia gravis.重症肌无力的治疗策略。
Ann N Y Acad Sci. 1993 Jun 21;681:515-28. doi: 10.1111/j.1749-6632.1993.tb22935.x.
4
Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.重症肌无力的长期皮质类固醇治疗：116例患者的报告。
Ann Neurol. 1984 Mar;15(3):291-8. doi: 10.1002/ana.410150316.
5
High-dose intravenous gammaglobulin for myasthenia gravis.大剂量静脉注射丙种球蛋白治疗重症肌无力
Lancet. 1984 Feb 18;1(8373):406-7. doi: 10.1016/s0140-6736(84)90469-0.
6
High-dose intravenous immunoglobulin in the management of myasthenia gravis.大剂量静脉注射免疫球蛋白治疗重症肌无力
Arch Intern Med. 1986 Jul;146(7):1365-8.
7
Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis.静脉注射免疫球蛋白重复给药对重症肌无力的影响。
Am J Med Sci. 1988 May;295(5):438-43. doi: 10.1097/00000441-198805000-00005.
8
Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.静脉注射免疫球蛋白对重症肌无力患者外周血B细胞、T细胞及多形核细胞的即时影响
J Clin Immunol. 1988 Jan;8(1):23-31. doi: 10.1007/BF00915153.
9
Treatment of myasthenia gravis with high-dose intravenous immunoglobulin.大剂量静脉注射免疫球蛋白治疗重症肌无力
Acta Neurol Scand. 1991 Aug;84(2):81-4. doi: 10.1111/j.1600-0404.1991.tb04912.x.
10
Manipulating the immune system with immune globulin.
N Engl J Med. 1992 Jan 9;326(2):107-16. doi: 10.1056/NEJM199201093260206.
Zotero 插件